LEVERAGING MANAGEMENT INFORMATION SYSTEMS(MIS) AND MACHINE LEARNING FOR PREDICTIVE DIABETES RISK ASSESSMENT

Urmi Haldar,
Department of Glasgow School for Business and Society, Glasgow Caledonian University, London campus, United Kingdom;
haldarurmi52@gmail.com

Md Mohibur Rahman,
MBA Program, Moulvibazar Government College, Moulvibazar, Bangladesh;
mdmohiburrahman885637@gmail.com

Md Alamgir Miah,
MBA Program (Management Information Systems), International American University, Los Angeles, California, USA;
mdalamgirmiah2016@gmail.com

Mukther Uddin,
MBA Program (Business Analytics), International American University, Los Angeles, California, USA;
muktheruddin1996@gmail.com

Sharjil Bin Yousuf,
MBA Program (Management Information Systems), International American University, Los Angeles, California, USA;
sharjil.yousuf@gmail.com

DOI: 10.36724/2664-066X-2025-11-2-2-14

SYNCHROINFO JOURNAL. Volume 11, Number 2 (2025). P. 2-14.

Abstract

Management information systems (MIS) coupled with artificial intelligence (AI) have received much interest in the healthcare sector, and specifically in predictive health management. The study utilizes health-related variables like blood glucose levels, body mass index, age, and pregnancy count to examine the potential application of machine learning models to predict the possibility of diabetes. The study will provide better healthcare decision-making through the early diagnosis and treatment of diabetes. The choice of Random Forest and Logistic Regression machine learning algorithms was based on the fact that they can handle intricate data and can also produce reliable risk estimates. The data that was studied included common health factors that appear in Electronic Health Records (EHR). Two of the examples of data preparation operations that strengthened the models were normalization and missing values. Random Forest had better results in all the key performance metrics, such as ROC-AUC (0.98 vs. 0.82), recall (87.90% vs. 83.20%), accuracy (85.60% vs. 81.50%), and precision (84.20% vs. 80.10%), than Logistic Regression. It has been revealed that the Random Forest model is more successful in determining the diabetes risks, which is essential to early intervention and prevention. Based on these findings, the application of AI-based devices in the healthcare management information system (HMIS) is increasingly becoming useful. These machine learning algorithms can significantly increase early detection of diabetes, decrease misdiagnosis, and offer more specific treatment that will benefit patients and save the healthcare system.

Keywords:  MIS, Health Business Analytics, Artificial Intelligence, ESG, Healthcare, Diabetics Predictive Analytics

References

[1]  J. Bajwa, U. Munir, A. Nori, and B. Williams, “Artificial intelligence in healthcare: transforming the practice of medicine,” Future Healthc. J., vol. 8, no. 2, pp. e188-e194, Jul. 2021, doi: 10.7861/fhj. 2021-0095.

[2]  X. Li et al., “Interpretable machine learning method to predict the risk of pre-diabetes using a nationwide cross-sectional data: evidence from CHNS,” BMC Public Health, vol. 25, no. 1, p. 1145, Mar. 2025, doi: 10.1186/s12889-025-22419-7.

[3] M. Talebi Moghaddam et al., “Predicting diabetes in adults: identifying important features in unbalanced data over a 5-year cohort study using a machine learning algorithm,” BMC Med. Res. Methodol., vol. 24, no. 1, p. 220, Sep. 2024, doi: 10.1186/s12874-024-02341-z.

[4]  M. S. Islam, M. Minul Alam, A. Ahamed, and S. I. Ali Meerza, “Prediction of Diabetes at Early Stage using Interpretable Machine Learning,” in SoutheastCon 2023, Orlando, FL, USA: IEEE, Apr. 2023, pp. 261–265. doi: 10.1109/SoutheastCon51012.2023.10115152.

[5]  C. Rose and J. H. Chen, “Learning from the EHR to implement AI in healthcare,” Npj Digit. Med., vol. 7, no. 1, p. 330, Nov. 2024, doi: 10.1038/s41746-024-01340-0.

[6] H. R. Karrar et al., “The Role of Artificial Intelligence in Advancing Hospital Management Information Systems: Review Article,” Saudi J. Clin. Pharm., vol. 4, no. 1, pp. 15–23, Jan. 2025, doi: 10.4103/sjcp.sjcp_42_24.

[7]  A. D. Sarma and M. Devi, “Artificial intelligence in diabetes management: transformative potential, challenges, and opportunities in healthcare,” Hormones, vol. 24, no. 2, pp. 307–322, Jun. 2025, doi: 10.1007/s42000-025-00644-4.

[8] R. Parab et al., “Artificial Intelligence in Diabetes Care: Applications, Challenges, and Opportunities Ahead,” Endocr. Pract., doi: 10.1016/j.eprac.2025.07.008.

[9] M. Khalifa and M. Albadawy, “Artificial intelligence for diabetes: Enhancing prevention, diagnosis, and effective management,” Comput. Methods Programs Biomed. Update, vol. 5, p. 100141, 2024, doi: 10.1016/j.cmpbup.2024.100141.

[10] S. C. Y. Wang, G. Nickel, K. P. Venkatesh, M. M. Raza, and J. C. Kvedar, “AI-based diabetes care: risk prediction models and implementation concerns,” Npj Digit. Med., vol. 7, no. 1, pp. 36, s41746-024-01034–7, Feb. 2024, doi: 10.1038/s41746-024-01034-7.

[11]  M. Kiran, Y. Xie, N. Anjum, G. Ball, B. Pierscionek, and D. Russell, “Machine learning and artificial intelligence in type 2 diabetes prediction: a comprehensive 33-year bibliometric and literature analysis,” Front. Digit. Health, vol. 7, p. 1557467, Mar. 2025, doi: 10.3389/fdgth. 2025.1557467.

[12] P. B. Khokhar, C. Gravino, and F. Palomba, “Advances in artificial intelligence for diabetes prediction: insights from a systematic literature review,” Artif. Intell. Med., vol. 164, p. 103132, Jun. 2025, doi: 10.1016/j.artmed.2025.103132.

[13] O. Ali, W. Abdelbaki, A. Shrestha, E. Elbasi, M. A. A. Alryalat, and Y. K. Dwivedi, “A systematic literature review of artificial intelligence in the healthcare sector: Benefits, challenges, methodologies, and functionalities,” J. Innov. Knowl., vol. 8, no. 1, p. 100333, Jan. 2023, doi: 10.1016/j.jik.2023.100333.

[14] Md. Faiyazuddin et al., “The Impact of Artificial Intelligence on Healthcare: A Comprehensive Review of Advancements in Diagnostics, Treatment, and Operational Efficiency,” Health Sci. Rep., vol. 8, no. 1, p. e70312, Jan. 2025, doi: 10.1002/hsr2.70312.

[15] H. Ni, J. Miao, and J. Chen, “Advanced Machine Learning did not Surpass Traditional Logistic Regression in First-Trimester Gestational Diabetes Mellitus Prediction: A Retrospective Single-Center Study from Eastern China,” Int. J. Gen. Med., vol. 18, pp. 2263–2274, Apr. 2025, doi: 10.2147/IJGM.S513064.

[16] Y. Wu et al., “Novel binary logistic regression model based on feature transformation of XGBoost for type 2 Diabetes Mellitus prediction in healthcare systems,” Future Gener. Comput. Syst., vol. 129, pp. 1–12, Apr. 2022, doi: 10.1016/j.future.2021.11.003.

[17] Y. Fan, “Diabetes diagnosis using a hybrid CNN LSTM MLP ensemble,” Sci. Rep., vol. 15, no. 1, p. 26765, jul. 2025, doi: 10.1038/s41598-025-12151-y.

[18] F. Rustam et al., “Enhanced detection of diabetes mellitus using novel ensemble feature engineering approach and machine learning model,” Sci. Rep., vol. 14, no. 1, p. 23274, Oct. 2024, doi: 10.1038/s41598-024-74357-w.

[19] K. Abnoosian, R. Farnoosh, and M. H. Behzadi, “Prediction of diabetes disease using an ensemble of machine learning multi-classifier models,” BMC Bioinformatics, vol. 24, no. 1, p. 337, Sep. 2023, doi: 10.1186/s12859-023-05465-z.

[20] P. Yang and B. Yang, “Development and validation of predictive models for diabetic retinopathy using machine learning,” PLOS ONE, vol. 20, no. 2, p. e0318226, Feb. 2025, doi: 10.1371/journal.pone.0318226.

[21] Y. Li et al., “Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis,” Front. Endocrinol., vol. 16, p. 1495306, Mar. 2025, doi: 10.3389/fendo. 2025.1495306.

[22] M. Talebi Moghaddam et al., “Predicting diabetes in adults: identifying important features in unbalanced data over a 5-year cohort study using a machine learning algorithm,” BMC Med. Res. Methodol., vol. 24, no. 1, p. 220, Sep. 2024, doi: 10.1186/s12874-024-02341-z.

[23] M. Matboli et al., “Machine learning-based stratification of prediabetes and type 2 diabetes progression,” Diabetol. Metab. Syndr., vol. 17, no. 1, p. 227, Jun. 2025, doi: 10.1186/s13098-025-01786-6.

[24] J.-E. Ding et al., “Large language multimodal models for new-onset type 2 diabetes prediction using five-year cohort electronic health records,” Sci. Rep., vol. 14, no. 1, p. 20774, Sep. 2024, doi: 10.1038/s41598-024-71020-2.

[25] E. Dritsas and M. Trigka, “Data-Driven Machine-Learning Methods for Diabetes Risk Prediction,” Sensors, vol. 22, no. 14, p. 5304, Jul. 2022, doi: 10.3390/s22145304.